✦ LIBER ✦

High Efficacy of First-Line Gefitinib in Non-Asian Patients with EGFR-Mutated Lung Adenocarcinoma

✍ Scribed by Moiseyenko, Vladimir M.; Procenko, Svetlana A.; Levchenko, Evgeny V.; Barchuk, Alexey S.; Moiseyenko, Fedor V.; Iyevleva, Aglaya G.; Mitiushkina, Nathalia V.; Togo, Alexandr V.; Semionov, Igor I.; Ivantsov, Alexandr O.; Matsko, Dmitry E.; Imyanitov, Evgeny N.

Book ID: 119985262
Publisher: S. Karger AG
Year: 2010
Tongue: English
Weight: 474 KB
Volume: 33
Category: Article
ISSN: 0378-584X
DOI: 10.1159/000302729

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-Line Gefitinib in Patients With Ad

First-Line Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR Mutations

✍ Sequist, L. V.; Martins, R. G.; Spigel, D.; Grunberg, S. M.; Spira, A.; Janne, P 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 228 KB

Impact of physical size on gefitinib eff

Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutations

✍ Ichihara, Eiki; Hotta, Katsuyuki; Takigawa, Nagio; Kudo, Kenichiro; Kato, Yuka; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 587 KB

25 A retrospective analysis of patients

25 A retrospective analysis of patients with advanced EGFR mutated lung cancer treated with either first line erlotinib or gefitinib

✍ Thillai, K.; Soultati, A.; Montes, A.; Karapanagiotou, E.; Spicer, J.; Lal, R. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Influence of first-line chemotherapy and

Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer

✍ Wu, Jenn-Yu; Yu, Chong-Jen; Shih, Jin-Yuan; Yang, Chih-Hsin; Yang, Pan-Chyr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Activity of pemetrexed and high-dose gef

Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib

✍ Ying Yuan, Chunwen Tan, Modan Li, Hong Shen, Xuefeng Fang, Yinghong Hu, Shenglin 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 305 KB

26 Audit of gefitinib for the first-line

26 Audit of gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer in patients with EGFR mutation

✍ Douglas, R.; Campbell, L.; McAleese, J.; Scullin, P. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 43 KB